Objective: To observe the time interval between stroke onset and hospital arrival (time-to-hospital) in acute ischemic stroke patients and analyze its putatively associated factors.

Methods: During the period from November 1, 2006 to August 31, 2008, patients with acute ischemic stroke admitted consecutively to the Department of Neurology, Ninth Hospital, Shanghai, were enrolled in the study. Information of the patients was registered including the time-to-hospital, demographic data, history of stroke, season at attack, neurological symptom at onset, etc. Characteristics of the patients were analyzed and logistic regression analyses were conducted to identify factors associated with the time-to-hospital.

Results: There were 536 patients in the study, 290 (54.1%) males and 246 (45.9%) females. The median time-to-hospital was 8h (ranged from 0.1 to 300 h) for all patients. Within 3h after the onset of stroke, 162 patients (30.2%) arrived at our hospital; and within 6h, 278 patients (51.9%). Patients with a history of stroke, unconsciousness at onset, or a high NIHSS score at admission had significantly less time-to-hospital.

Conclusion: The time interval between stroke onset and hospital arrival was <6h for around half of our patients with acute cerebral ischemic stroke. A history of stroke and severe symptoms at onset were significantly associated with shorter time-to-hospital. The results might indicate that the knowledge of stroke and understanding the importance of seeking immediate medical help after stroke onset of patients and their relatives could significantly influence their actions.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2010.09.004DOI Listing

Publication Analysis

Top Keywords

time interval
12
interval stroke
12
stroke onset
12
onset hospital
12
hospital arrival
12
acute ischemic
12
ischemic stroke
12
patients
10
stroke
9
stroke patients
8

Similar Publications

Background: Primary acquired nasolacrimal duct obstruction (PANDO) is a condition in which tear ducts are blocked, leading to epiphora and dacryocystitis. This systematic review and meta-analysis aimed to measure the ability of transcanalicular dacryocystorhinostomy (TC-DCR) as an alternative approach to PANDO compared to traditional external dacryocystorhinostomy (EX-DCR).

Methods: Our search included Embase, Medline, and the Cochrane Central Register of Controlled Trials (CENTRAL).

View Article and Find Full Text PDF

Introduction: The effectiveness of AZD7442 (tixagevimab/cilgavimab) against COVID-19 hospitalizations was determined at 3 and 6 months among immunocompromised individuals in Israel during different variant circulations.

Methods: This was a retrospective cohort study using data from Clalit Health Services in Israel. Immunocompromised individuals eligible to receive AZD7442 300 mg between 15 February and 11 December 2022 were identified.

View Article and Find Full Text PDF

Background: Currently, serum PSA is the most commonly used screening tool in clinical practice. However, PSA levels in the range of 4-10 ng/ml are considered the 'grey zone' of prostate cancer screening. Patients within this range need to be further evaluated using additional parameters such as PSA ratio, PSA density, and other indices to determine the necessity of prostate biopsy (PBx).

View Article and Find Full Text PDF

Aims: To compare adherence to perindopril/amlodipine/atorvastatin combination administrated as a polypill (one pill) vs separate tablets.

Methods: Using the healthcare utilization database of Lombardy (Italy), 1 110 patients who received the perindopril/amlodipine/atorvastatin polypill during 2019-2021 were matched with 1 110 patients prescribed the same combination in separate tablets or as two antihypertensive drugs in a single tablet and the lipid-lowering drug tablet separately. Adherence to treatment was assessed over the year after the first perindopril/amlodipine/atorvastatin dispensation as the proportion of the follow-up days covered by prescription (PDC).

View Article and Find Full Text PDF

Background: Injury prevalence is a metric which can be used to understand healthcare utilisation and prioritise injuries based on the magnitude of the injury rate. Given the ageing population in high-income countries and subsequently ageing of the injured population, the probability of long-term or permanent consequences of injuries is also likely to increase. By understanding past trends and exploiting patterns of prevalence injury rates (PIRs), future PIRs can be predicted.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!